User Guide
Why can I only view 3 results?
You can also view all results when you are connected from the network of member institutions only. For non-member institutions, we are opening a 1-month free trial version if institution officials apply.
So many results that aren't mine?
References in many bibliographies are sometimes referred to as "Surname, I", so the citations of academics whose Surname and initials are the same may occasionally interfere. This problem is often the case with citation indexes all over the world.
How can I see only citations to my article?
After searching the name of your article, you can see the references to the article you selected as soon as you click on the details section.
Institutional References Quartile Statistics FAQ User Guide Contact us
Institutional Application Application for Journals
Türkçe English
  Citation Number 7
 Views 18
 Downloands 2
Menu
Mendeley
Endnote
COVID-19 Tanı Testleri, Tedavisindeki Aşılar ve İlaçlar; Güncel Durum
2021
Journal:  
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Author:  
DOI:  
10.32708/uutfd.957260
Abstract:

COVID-19 (Koronavirüs Hastalığı 19) olarak adlandırılan SARS-CoV-2 (Şiddetli akut solunum yolu sendromu koronavirüs-2) virüsünün neden olduğu enfeksiyon başlangıçta Aralık 2019’da Çin'de tespit edilmiştir ve daha sonra dünyaya hızla yayılmıştır. 13 Ocak 2020 tarihinde Tayland Halk Sağlığı Bakanlığı Çin'in Wuhan şehrinde yaşayan 8 Ocak 2020 tarihinde Tayland’a giden 61 yaşında Çinli bir kadında ilk importe olguyu bildirmiştir. Daha sonra 11 Mart'ta Dünya Sağlık Örgütü (DSÖ) bu salgını küresel bir pandemi ilan etmiştir. Hastalığın yayılmasını önlemek ve pandemiyi kontrol etmek için ilaçların etkinliği araştırılmakta olup çok sayıda COVID-19 aşı adayı ve ilaç adayı geliştirilmektedir. ABD- Gıda ve İlaç İdaresi (FDA), Aralık 2020'de sırasıyla Pfizer ve Moderna tarafından geliştirilen iki mRNA aşısı için acil kullanım onayı yayınlamıştır. Şu anda geliştirilmekte olan diğer COVID-19 aşıları mRNA, DNA, viral vektör, subünite, inaktive edilmiş ve canlı zayıflatılmış aşıları kapsayan çeşitli platformlara dayanmaktadır. Bu derlemede COVID-19 tanı ve/veya tedavisinde kullanılan testler, aşılar ve ilaçların rolünü incelenmektedir.

Keywords:

COVID-19 Diagnostic Tests, Vaccines and Medicines in Treatment; Current Status
2021
Journal:  
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Author:  
DOI:  
10.32708/uutfd.957260
Abstract:

The infection caused by the SARS-CoV-2 virus, known as COVID-19 (Coronavirus Disease 19), was initially detected in December 2019 in China and then rapidly spread to the world. On January 13, 2020, the Thai Ministry of Public Health the first incident in a 61-year-old Chinese woman traveling to Thailand on January 8, 2020, living in the Chinese city of Wuhan. On March 11, the World Health Organization (WHO) declared the epidemic a global pandemic. The effectiveness of drugs is being studied to prevent the spread of the disease and to control the pandemic, and a large number of COVID-19 vaccine candidates and drug candidates are being developed. The U.S. Food and Drug Administration (FDA) has issued emergency use approval for two mRNA vaccines developed by Pfizer and Moderna in December 2020. Other COVID-19 vaccines currently being developed are based on a variety of platforms that include mRNA, DNA, viral vectors, subunity, inactive and live weakened vaccines. This collection examines the role of tests, vaccines and medications used in the diagnosis and/or treatment of COVID-19.

Keywords:

Covid-19 Diagnostic Tests, Vaccines and Medicines In Its Treatment; Current Status
2021
Journal:  
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Author:  
DOI:  
10.32708/uutfd.957260
Abstract:

The infection caused by the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus-2) virus, called COVID-19 (Coronavirus disease 19), was initially detected in China in December 2019, and then spread rapidly around the world. On January 13, 2020, the Ministry of Public Health of Thailand reported the first imported case in a 61-year-old Chinese woman living in Wuhan, China, who went to Thailand on January 8, 2020. Later, on March 11, the World Health Organization (WHO) declared this outbreak a global pandemic. The effectiveness of drugs is being investigated to prevent the spread of the disease and control the pandemic, and many COVID-19 vaccine candidates and drug candidates are being developed. The U.S. Food and Drug Administration (FDA) issued emergency-use approval for two mRNA vaccines developed by Pfizer and Moderna, respectively, in December 2020. Other COVID-19 vaccines currently in development are based on a variety of platforms including mRNA, DNA, viral vector, subunit, inactivated and live attenuated vaccines. This review examines the role of tests, vaccines and drugs used in the diagnosis and/or treatment of COVID-19.

Keywords:

Citation Owners
Attention!
To view citations of publications, you must access Sobiad from a Member University Network. You can contact the Library and Documentation Department for our institution to become a member of Sobiad.
Off-Campus Access
If you are affiliated with a Sobiad Subscriber organization, you can use Login Panel for external access. You can easily sign up and log in with your corporate e-mail address.
Similar Articles
1. Covid-19 Pandemisinde İmmünonütrientlerin Önemi: Arjinin, Glutamin ve Omega-3 Yağ Asitleri
2022


  Details
 Download PDF
2. Sağlık Çalışanlarında İnaktive SARS-CoV-2 Aşısı Sonrası Gelişen Ani Tip Sistemik Aşırı Duyarlılık Reaksiyonları
2022


  Details
 Download PDF
3. COVID-19 ve terapötik yaklaşımlardaki ilerleme: bir gözden geçirme
2024


  Details
 Download PDF
4. Avoiding an imminent catastrophe from COVID-19 pandemic in Africa: The need to urgently prohibit mass gatherings
2020


  Details
 Download PDF
5. Covid-19’a Histopatolojik Bir Bakış: Akciğer, Böbrek, Beyin, Karaciğer
2020


  Details
 Download PDF
6. COVID-19 Hastalarında Potansiyel İmmünolojik Tedaviler
2021


  Details
 Download PDF
Uludağ Üniversitesi Tıp Fakültesi Dergisi

Field :   Sağlık Bilimleri

Journal Type :   Ulusal

Metrics
Article : 880
Cite : 2.687
2023 Impact : 0.023
Details
Uludağ Üniversitesi Tıp Fakültesi Dergisi